DNA Funded vs Blue Guardian: Which Prop Firm Is Better?
Choosing between DNA Funded and Blue Guardian comes down to whether you prioritize lower entry costs or more flexible daily loss limits. Blue Guardian offers a $113 cheaper challenge fee for $100K accounts and allows news trading, while DNA Funded provides 4% daily loss room versus Blue Guardian's 3%. Both firms offer similar profit targets and payout structures, but differ significantly in their trading restrictions and platform options. This comparison examines their challenge costs, risk parameters, and trading conditions to help you determine which better fits your trading style.
DF
DNA Funded
Est. 2023 · Australia
4.5
2,000 reviews
VS
3 wins
5 ties
5 wins
BG
Blue Guardian
Est. 2022 · N/A
4.3
1,500 reviews
Feature
DNA Funded
Blue Guardian
Challenge Price ($100K)
$619
$506✓ Lower entry cost
Phase 1 Profit Target
10%
10%
Max Daily Loss
4%✓ More daily loss room
3%
Max Total Loss
6%
6%
Min Trading Days
5 days
None✓ No minimum
Time Limit (Phase 1)
No limit
No limit
Payout Split
N/A
80% (up to 90%)
Payout Frequency
N/A
instant
DNA Funded
Pros
+Multiple challenge types including 1-phase, 2-phase, rapid, and instant funding options
+Accounts available up to $200,000 with competitive pricing
+Swap-free accounts with no overnight interest charges
+Regular tournaments with substantial prize pools up to $750K
+26% discount promotion and other active promotional offers
Cons
−Limited to TradeLocker platform only (no MT4/MT5 support)
−Restrictive trading policies prohibiting many common strategies like hedging and grid trading
−Lower leverage compared to many competitors (1:30 for forex vs 1:100+ elsewhere)
−Relatively new firm established in 2023 with shorter track record
Blue Guardian
Pros
+Instant funding accounts available - skip evaluation phases entirely
+Scale up to $4M in funding capacity
+Instant payouts and 24-hour payout guarantee available
+Multiple account types including 1-step, 2-step, and 3-step challenges
+100% refundable fees after fourth payout
Cons
−Relatively new firm established in 2022
−Lower leverage ratios compared to some competitors (1:30 max for most instruments)
−Limited transparency on company background and headquarters location
−Higher fees for larger account sizes compared to some established competitors
Our Verdict
Which Should You Choose?
Blue Guardian suits cost-conscious traders and news traders who want maximum flexibility in their approach. With a $506 challenge fee versus DNA Funded's $619, plus unrestricted news trading and no minimum trading days requirement, it's ideal for traders who want to keep costs low and trade major economic events. The 3% daily loss limit is manageable for most disciplined traders.
DNA Funded works better for active traders who need breathing room on daily losses and prefer newer firms with higher review volumes. The 4% daily loss limit provides a meaningful buffer for volatile trading sessions, and their 4.5/5 Trustpilot rating from 2,000 reviews suggests strong trader satisfaction. However, the 5-day minimum trading requirement and news trading restrictions limit flexibility.
For most traders, Blue Guardian offers better value due to lower costs and fewer restrictions, making it the stronger choice unless you specifically need that extra 1% daily loss room that DNA Funded provides.
Choose DNA Funded if:
→Multiple challenge types including 1-phase, 2-phase, rapid, and instant funding options
→Accounts available up to $200,000 with competitive pricing
→Swap-free accounts with no overnight interest charges
→Regular tournaments with substantial prize pools up to $750K
Choose Blue Guardian if:
→Instant funding accounts available - skip evaluation phases entirely
→Scale up to $4M in funding capacity
→Instant payouts and 24-hour payout guarantee available
→Multiple account types including 1-step, 2-step, and 3-step challenges
Disclaimer:This comparison is for informational purposes only. Prop firm rules change regularly — always verify current terms on each firm's official website before purchasing a challenge. This is not financial advice. Updated 2026-03-08.